Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase (original) (raw)

• Daum, G. et al. The ins and cuts of Raf kinases. Trends Biol. Sci. 19, 474–480 (1994).
  Article CAS Google Scholar
• Nishida, E. & Gotoh, Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biol. Sci. 18, 128–131 (1993).
  Article CAS Google Scholar
• Vojtek, A.B., Hollenberg, S.M. & Cooper, J.A. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74, 205–214 (1993).
  Article CAS Google Scholar
• Zhang, X.F. et al. Normal and oncogenic p21_ras_ proteins bind to the amino-terminal regulatory domain of c-_raf_-1. Nature 364, 308–313 (1993).
  Article CAS Google Scholar
• Warne, P.E., Viciana, P.R. & Downward, J. Direct interaction of ras and the amino-terminal region of _raf_-1 in vitro. Nature 364, 352–355 (1993).
  Article CAS Google Scholar
• Fabian, J.R., Vojtek, A.B., Cooper, J.A. & Morrison, D.K. A single amino acid change in _raf_-1 inhibits ras binding and alters _raf_-1 function. Proc. Natl. Acad. Sci. USA 91, 5982–5986 (1984).
  Article Google Scholar
• Bos, J.L. The ras gene family and human carcinogenesis. Mutat. Res. 195, 255–271 (1988).
  Article CAS Google Scholar
• Bos, J.L. ras oncogenes in human cancer: A review. Cancer Res. 49, 4682–4689 (1989).
  CAS Google Scholar
• Rapp, U.R. et al. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. USA 80, 4218–4222 (1983).
  Article CAS Google Scholar
• Heidecker, G. et al. Mutational activation of C-_raf_-1 and definition of the minimal transforming sequence. Mol Cell. Biol. 10, 2503–2512 (1990).
  Article CAS Google Scholar
• Stanton, V.P., Jr. & Cooper, G.M. Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences. Mol. Cell. Biol. 7, 1171–1179 (1987).
  Article CAS Google Scholar
• Fabian, J.R., Daar, I.O. & Morrison, D.K. Critical tyrosine residues regulate the enzymatic and biological activity of _raf_-1 kinase. Mol. Cell. Biol. 13, 7170–7179 (1993).
  Article CAS Google Scholar
• Shimizu, K. et al. Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer. Proc. Natl. Acad. Sci. USA 82, 5641–5645 (1985).
  Article CAS Google Scholar
• Fukui, M. et al. Detection of a _raf_-related and two other transforming DNA sequences in human tumors maintained in nude mice. Proc. Natl. Acad. Sci. USA 81, 5954–5958 (1985).
  Article Google Scholar
• Rapp, U.R. et al. Role of raf oncogenes in lung carcinogenesis. Proc. from the Intl. Conf. on Hormones, Growth Factors and Oncogenes in Pulmonary Carcinoma (ed. Dunbar, B.S.) 122–137 (Plenum, London, 1987).
  Google Scholar
• Rapp, U.R., Cleveland, J.L. & Storm, S.M. Oncogenes: Clinical Relevance. in Proceedings from Modern Trends in Leukemia VII: Hematology and Blood Transfusion. (eds. Neth, R., Gallo, R., Greaves, M.F. & Vanka, G.) 69–77 (Springer, Berlin, 1987).
  Google Scholar
• Rapp, U.R., Cleveland, J.L., Bonner, T.I. & Storm, S.M. The raf oncogenes. in The Oncogene Handbook. (eds. Reddy, E.P., Skalka, A.M. & Curran, T.) 213–251 (Elsevier Science Publ., Amsterdam, 1988).
  Google Scholar
• Wagner, R.W. The state of the art in antisense research. Nature Med. 1, 1116–1118 (1995).
  Article CAS Google Scholar
• Stein, C.A. Does antisense exist? Nature Med. 1, 1119–1121 (1995).
  Article CAS Google Scholar
• Crooke, S.T. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32, 329–376 (1993).
  Article Google Scholar
• Monia, B.P. et al. Evaluation of 2′ modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 14514–14522 (1993).
  CAS PubMed Google Scholar
• Bennett, C.F. et al. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023–1033 (1992).
  CAS Google Scholar
• Monia, B.P. et al. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267, 19954–19962 (1992).
  CAS PubMed Google Scholar
• Crooke, R.M., Graham, M.J., Cooke, M.E. & Crooke, S.T. In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. J. Pharmacol. Exp. Ther. 275, 462–473 (1995).
  CAS PubMed Google Scholar
• Crooke, S.T. et al. Pharmacokinetic properties of several novel oligonucleotide analogues in mice. J. Pharmacol. Exp. Ther. (in the press).
• Hoke, G. et al. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res. 19, 5743–5748 (1991).
  Article CAS Google Scholar
• Cailleau, R., Young, R., Olive, M. & Reeves, W.J., Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53, 661–674 (1974).
  Article CAS Google Scholar
• Shih, C. & Weinberg, R.A. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29, 161–169 (1982).
  Article CAS Google Scholar
• Dean, N.M. & McKay, R. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 91, 11762–11766 (1994).
  Article CAS Google Scholar
• Stepkowski, S.M., Tu, Y., Condon, T.P. & Bennett, C.F. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol. 153, 5336–5346 (1994).
  CAS PubMed Google Scholar
• Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–1749 (1993).
  Article CAS Google Scholar
• Uhlenbeck, O.C. Complementary oligonucleotide binding to transfer RNA. J. Mol. Biol. 65, 25–41 (1972).
  Article CAS Google Scholar
• Freier, S.M. & Tinoco, I., Jr. The binding of complementary oligoribonucleotides to yeast initiator transfer RNA. Biochemistry 14, 3310–3314 (1975).
  Article CAS Google Scholar
• Herschlag, D. & Cech, T.R. Catalysis of RNA cleavage by the Tetrahymena thermophila ribozyme: Kinetic description of the reaction of an RNA substrate that forms a mismatch at the active site. Biochemistry 29, 10172–10780 (1990).
  Article CAS Google Scholar
• Lima, W.F., Monia, B.P., Ecker, D.J. & Freier, S.M. Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry 31, 12055–12061 (1992).
  Article CAS Google Scholar
• Bacon, T.A. & Wickstrom, E. Walking along human C-myc mRNA with antisense oligodeoxynucleotides: Maximum efficacy at the 5′ cap region. Oncogene Res. 6, 13–19 (1991).
  CAS PubMed Google Scholar
• Chiang, M.-Y. et al. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266, 18162–18172 (1991).
  CAS PubMed Google Scholar
• Yamamoto, S. et al. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36, 983–997 (1992).
  Article CAS Google Scholar
• Kuramoto, E. et al. Oligonucleotide sequences required for natural killer cell activation. Jpn. J. Cancer Res. 83, 1128–1131 (1992).
  Article CAS Google Scholar
• Yamamoto, T., Yamamoto, S., Kataoka, T. & Tokunaga, T. Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol. Immunol. 38, 831–836 (1994).
  Article CAS Google Scholar
• Reddy, E.P. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 220, 1061–1063 (1983).
  Article CAS Google Scholar
• Valenzuela, D.M. & Groffen, J. Four human carcinoma cell lines with novel mutations in position 12 of C-K-ras oncogene. Nucleic Acids Res. 14, 844–852 (1986).
  Article Google Scholar
• Bennett, C.F. et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate-induced colitis in mice. J. Pharmacol. Exp. Ther. (in the press).
• Ausubel, F.M. et al. (eds.) Preparation and analysis of RNA. in Current Protocols in Molecular Biology. (Greene Publishing Assoc. and Wiley Interscience, New York, 1987).
  Google Scholar
• Meyer, T. et al. A derivative of staurosporin (CGP 41 251) shows selectivity for protein kinase C inhibition and in vivo antitumor activity. Int. J. Cancer 43, 851–856 (1989).
  Article CAS Google Scholar
• Blumer, K.J. & Johnson, G.L. Diversity in function and regulation of MAP kinase pathways. Trends Biol. Sci. 19, 236–240 (1994).
  Article CAS Google Scholar
• Porras, A., Muszynski, K., Rapp, U.R. & Santos, E. Dissociation between activation of _Raf_-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK) cascade in the insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells. J. Biol. Chem. 269, 12741–12748 (1994).
  CAS PubMed Google Scholar
• Indolfi, C. et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 1, 541–545 (1995).
  Article CAS Google Scholar